The reported statements, read against the company's own industry.
Financials view
Market Capitalization
393.18MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue (TTM)
994.67MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Profit Margin
-28.46%
vs Health Information Services peers
Updated Sep 27, 2026
Beta
0.8870x
vs all stocks
Updated Sep 27, 2026
52-Week Change
-55.90%
vs all stocks
Updated Sep 27, 2026
Market Capitalization
393.18MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Enterprise Value
5.08BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Forward P/E
3.17x
vs Health Information Services peers
Updated Sep 27, 2026
Price to Sales (TTM)
0.3953x
vs Health Information Services peers
Updated Sep 27, 2026
Enterprise to Revenue
5.11x
vs Health Information Services peers
Updated Sep 27, 2026
Enterprise to EBITDA
9.41x
vs Health Information Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9×.Updated Sep 27, 2026
Gross Margin
67.31%
vs Health Information Services peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 72.97%.Updated Sep 27, 2026
Profit Margin
-28.46%
vs Health Information Services peers
Updated Sep 27, 2026
Operating Margin
12.80%
vs Health Information Services peers
Updated Sep 27, 2026
Return on Assets (TTM)
1.19%
vs Health Information Services peers
Updated Sep 27, 2026
Revenue (TTM)
994.67MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue per Share (TTM)
59.68USDUpdated Sep 27, 2026
Quarterly Revenue Growth
6.60%
vs Health Information Services peers
Updated Sep 27, 2026
Gross Profit (TTM)
725.77MUSD
vs all stocks (USD)
Updated Sep 27, 2026
EBITDA (TTM)
564.07MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Net Income (TTM)
-283.11MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Quarterly Earnings Growth (YoY)
6.59%
vs Health Information Services peers
Updated Sep 27, 2026
Operating Cash Flow (TTM)
133.03MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Levered Free Cash Flow (TTM)
102.99MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 27, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Sep 27, 2026
Minority Interest (Equity)
6.72MUSDFY2025 · Dec 31, 2025
Revenue
965.41MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
316.37MUSDFY2025 · Dec 31, 2025
Gross Profit
649.05MUSDFY2025 · Dec 31, 2025
Operating Income
45.06MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-373.08MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-88.80MUSDFY2025 · Dec 31, 2025
Net Income
-284.28MUSDFY2025 · Dec 31, 2025
EBIT
18.94MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
495.07MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
158.56MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
1.56MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
392.02MUSDFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-284.28MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
0.00USDFY2025 · Dec 31, 2025
Operating Cash Flow
75.93MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-53.67MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
28.34MUSDFY2025 · Dec 31, 2025
Income Tax Paid
44.49MUSDFY2025 · Dec 31, 2025
Interest Paid
282.75MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-284.28MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
448.45MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-128.51MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
27.82MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
70.01MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-26.57MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-25.86MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-5.13MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-129.60MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-4.75MUSDFY2025 · Dec 31, 2025
Sale of Investments
13.33MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-121.02MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
230.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-221.02MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-8.36MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
621.00KUSDFY2025 · Dec 31, 2025
Shares Outstanding
16.94MSharesUpdated Sep 27, 2026
Float Shares
5.67MSharesUpdated Sep 27, 2026
Shares Short
941.20KSharesUpdated Sep 27, 2026
Short Ratio
7.92days
vs all stocks
Updated Sep 27, 2026
Short % of Shares Outstanding
9.22%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 5.56%.Updated Sep 27, 2026
% Held by Insiders
7.26%
vs all stocks
Updated Sep 27, 2026
% Held by Institutions
90.21%
vs all stocks
Updated Sep 27, 2026
Total Cash (MRQ)
14.37MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Cash per Share (MRQ)
0.8480USDUpdated Sep 27, 2026
Total Debt (MRQ)
4.69BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Current Ratio (MRQ)
0.9950x
vs Health Information Services peers
Updated Sep 27, 2026
Book Value per Share (MRQ)
-17.39USDUpdated Sep 27, 2026
Total Assets
4.89BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
224.37MUSDFY2025 · Dec 31, 2025
Total Liabilities
5.06BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
4.66BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.79BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
261.36MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
16.81MUSDFY2025 · Dec 31, 2025
Accounts Receivable
127.61MUSDFY2025 · Dec 31, 2025
Accounts Payable
60.46MUSDFY2025 · Dec 31, 2025
Short-term Debt
19.39MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
6.05MUSDFY2025 · Dec 31, 2025
Long-term Debt
4.60BUSDFY2025 · Dec 31, 2025
Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-2.43BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
-167.18MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
138.73MUSDFY2025 · Dec 31, 2025
52-Week Low
11.50USDUpdated Sep 27, 2026
52-Week High
73.68USDUpdated Sep 27, 2026
52-Week Change
-55.90%
vs all stocks
Updated Sep 27, 2026
Beta
0.8870x
vs all stocks
Updated Sep 27, 2026
50-Day MA
32.28USDUpdated Sep 27, 2026
200-Day MA
27.43USDUpdated Sep 27, 2026
Avg 10-Day Volume
171.74KSharesUpdated Sep 27, 2026
Avg 30-Day Volume
136.71KSharesUpdated Sep 27, 2026
Diluted EPS (TTM)
-17.00USDUpdated Sep 27, 2026
Other Income / Expense
-27.68MUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Partial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone